Zepbound ( Tirzepatide ) Zepbound is a newer medication that combines both GLP-1 and GIP receptor agonist actions, impacting not only appetite but also other metabolic pathways
Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial
Experts recommend that people carefully follow medication dosages as prescribed, get proper education on how to fill syringes and never buy or use GLP-1 drugs from unregulated, online marketplaces or family and friends
Given the medication's appetite-suppressing effects, maximizing nutritional value in smaller portions becomes essential to prevent deficiencies while supporting metabolic health
This isnt harmful, but when bacterial populations change, bowel patterns often change with them
[1] For additional guidance, you can also contact the manufacturer (Novo Nordisk) directly with product quality concerns in addition to consulting your pharmacy or healthcare provider
